Skip to main content
Livermore
Livermore
ZHEN

Kodiak Sciences Inc.

KOD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001468748

No open-market purchases or sales by Kodiak Sciences Inc. insiders were filed in the last 90 days; 200 institutions reported holding it in 13F filings for Q2 2026, worth $2.36B in total; no superinvestor holds it.

Holders of 5% or more of KOD

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Kodiak Sciences Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of KOD
HolderLatest formStakeChangeFirst filedLatest filingFiling
Baker Bros. Advisors LP13D/A32.80%20.1M shares–Dec 19, 20251 filingDec 19, 2025SEC
Perlroth Victor13G/A11.00%6.16M shares–Feb 14, 20251 filingFeb 14, 2025SEC
Point72 Asset Management, L.P.13G5.50%2.91M sharesNewAug 19, 20251 filingAug 19, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

4 Schedule 13D and 13G filings on Kodiak Sciences Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on KOD
Filed (ET)FilerFormStakeChangeEvent dateFiling
Dec 19, 20254:22 PM ETBaker Bros. Advisors LPand 3 others13D/A32.80%20.1M shares–Dec 18, 2025SEC
Aug 19, 20255:26 PM ETPoint72 Asset Management, L.P.and 2 others13G5.50%2.91M sharesNewAug 15, 2025SEC
Apr 29, 20259:31 AM ETBlackRock, Inc.13G/A4.40%2.30M shares–Below 5%Mar 31, 2025SEC
Feb 14, 20254:02 PM ETPerlroth Victor13G/A11.00%6.16M shares–Dec 31, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Kodiak Sciences Inc. shares.

No Form 144 notices for Kodiak Sciences Inc. are on file.